NYSE Euronext Welcomes Leading Global Healthcare Supplier, Perrigo Company, to the New York Stock Ex

Updated

NYSE Euronext Welcomes Leading Global Healthcare Supplier, Perrigo Company, to the New York Stock Exchange

Perrigo Transfers Common Stock Listing to the NYSE from NASDAQ Global Select Market

NEW YORK--(BUSINESS WIRE)-- Allegan, Mich.-based Perrigo Company, a leading global provider of quality, affordable healthcare products, began trading on the New York Stock Exchange (NYSE) today under the ticker symbol "PRGO" after the transfer of its common stock listing to the NYSE from the NASDAQ Global Select Market. Joseph C. Papa, Chairman and CEO, accompanied by members of Perrigo's leadership team, rang The Opening Bell® to celebrate the company's first day of trading on the NYSE.

Perrigo Company CEO Joseph C. Papa, joined by members of the company's leadership team, rings the NY ...
Perrigo Company CEO Joseph C. Papa, joined by members of the company's leadership team, rings the NY ...

Perrigo Company CEO Joseph C. Papa, joined by members of the company's leadership team, rings the NYSE Opening Bell® to celebrate Perrigo's transfer of its common stock listing to the NYSE from NASDAQ. (Photo: Business Wire)


Perrigo Company is the third NASDAQ-100 Index company, following Infosys Ltd. (NYSE: INFY) and Teva Pharmaceuticals (NYSE: TEVA), to transfer its common stock listing to the NYSE within the past year and the fourth NASDAQ 100 company by market capitalization (following Infosys, Teva Pharmaceuticals and TD Ameritrade Holding Corp./NYSE: AMTD) to transfer since 2012.

About Perrigo Company:

From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com). (Source: Perrigo Company)

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: http://www.nyx.com.

Photos/Multimedia Gallery Available:http://www.businesswire.com/multimedia/home/20130606006049/en/



NYSE Euronext
Judy Shaw, 212-656-4290
jshaw@nyx.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS:

The article NYSE Euronext Welcomes Leading Global Healthcare Supplier, Perrigo Company, to the New York Stock Exchange originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement